Skip to the page

Data / Form D filings / Shuttle Pharmaceuticals Holdings, Inc.

Shuttle Pharmaceuticals Holdings, Inc.: Form D filings

Shuttle Pharmaceuticals Holdings, Inc., a technology company in Gaithersburg, MD, filed 9 Form D notices with the SEC between 2019 and 2026. The latest, on May 15, 2026, reports $10 million sold of a $10 million offering to 47 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
401 PROFESSIONAL DRIVE SUITE 260, Gaithersburg, MD, 20879
Phone
(240) 403-4212
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1757499

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 15, 2026New notice$9,955,000$9,955,00047Apr 30, 2026sec.gov
Nov 7, 2025New notice$2,500,624$2,499,998$6261Nov 3, 2025sec.gov
Jun 26, 2025New notice$4,250,000$4,250,0001Jun 20, 2025sec.gov
Oct 25, 2024New notice$1,300,000$790,000$510,0005Oct 14, 2024sec.gov
Jan 20, 2023New notice$4,000,000$4,000,0001Jan 11, 2023sec.gov
Aug 15, 2022New notice$500,000$125,000$375,0003Aug 1, 2022sec.gov
Feb 22, 2022New notice$2,000,000$365,000$1,635,00011Feb 8, 2022sec.gov
Jan 4, 2022New notice$500,000$500,0002Dec 28, 2021sec.gov
Jan 31, 2019New noticeIndefinite$912,50018Aug 1, 2018sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Christopher CooperExecutive Officer, DirectorCo-Chief Executive Officer
George ScorsisDirector
Adam ChambersDirector
Yuying LiangExecutive OfficerChief Financial Officer
Angel LirianoDirector
Ryan TrasoliniExecutive OfficerCo-Chief Executive Officer

Other technology companies in Maryland that filed recently

Every Form D from the week of May 11, 2026 · All recent filings in Maryland · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Shuttle Pharmaceuticals Holdings, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.